» Articles » PMID: 22984082

NLRP3 Inflammasome Activity is Negatively Controlled by MiR-223

Overview
Journal J Immunol
Date 2012 Sep 18
PMID 22984082
Citations 250
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammasomes are multiprotein signaling platforms that form upon sensing microbe- or damage-associated molecular patterns. Upon their formation, caspase-1 is activated, leading to the processing of certain proinflammatory cytokines and the initiation of a special type of cell death, known as pyroptosis. Among known inflammasomes, NLRP3 takes on special importance because it appears to be a general sensor of cell stress. Moreover, unlike other inflammasome sensors, NLRP3 inflammasome activity is under additional transcriptional regulation. In this study, we identify the myeloid-specific microRNA miR-223 as another critical regulator of NLRP3 inflammasome activity. miR-223 suppresses NLRP3 expression through a conserved binding site within the 3' untranslated region of NLRP3, translating to reduced NLRP3 inflammasome activity. Although miR-223 itself is not regulated by proinflammatory signals, its expression varies among different myeloid cell types. Therefore, given the tight transcriptional control of NLRP3 message itself, miR-223 functions as an important rheostat controlling NLRP3 inflammasome activity.

Citing Articles

The circulating plasma microRNA signature in human visceral leishmaniasis.

Roy R, Hudachek C, Bhushan Chauhan S, Kumar S, Kumar A, Zhanbolat B mSphere. 2025; 10(2):e0064624.

PMID: 39873510 PMC: 11853014. DOI: 10.1128/msphere.00646-24.


NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics.

Liu Y, Wang Y, Yan P, Cui N, Xu K, Liu D Biology (Basel). 2025; 14(1).

PMID: 39857301 PMC: 11761621. DOI: 10.3390/biology14010071.


Activation and evasion of inflammasomes during viral and microbial infection.

Ren D, Ye X, Chen R, Jia X, He X, Tao J Cell Mol Life Sci. 2025; 82(1):56.

PMID: 39833559 PMC: 11753444. DOI: 10.1007/s00018-025-05575-2.


The Role of Leukemia Inhibitory Factor in Cardiovascular Disease: Signaling in Inflammation, Coagulation, and Angiogenesis.

Rezaeeyan H, Moghimian-Boroujeni B, Abdolalian M, Javan M J Tehran Heart Cent. 2024; 19(1):6-13.

PMID: 39712364 PMC: 11659708. DOI: 10.18502/jthc.v19i1.15531.


Inflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies.

Scalavino V, Piccinno E, Giannelli G, Serino G Int J Mol Sci. 2024; 25(23).

PMID: 39684769 PMC: 11642578. DOI: 10.3390/ijms252313058.